Survey reveals how honesty about drug unknowns changes patient choices
NCT ID NCT07110597
Summary
This study was a large national survey to see how telling people about the unknowns and uncertainties of a new cancer drug affects their decisions. Over 3,000 US adults were asked if they would take a hypothetical new lung cancer drug, then some were given extra statements about what is still uncertain about the drug's evidence. The researchers measured if this changed how likely people were to take the drug, their understanding, and their trust in the information.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
London School of Economics and Political Science
London, United Kingdom
Conditions
Explore the condition pages connected to this study.